Annual Research Reports

Learn more about our commitment to clinical trials and the future of cancer care and beyond

Icon launched its inaugural Annual Research Report in 2020 reflecting the growth and maturity of the group’s clinical trial offering.

In line with Icon’s national and international expansion, investment in research remains a priority. We are utilising our long history and depth of clinical trials experience in Australia to continue to establish new research at existing Icon sites and build upon proven team structures to bring the same level of world-class trials to our centres across Singapore, Hong Kong and New Zealand.

View our achievements, milestones and future strategy in the our Annual Research Reports below.

2022 Report

2021 Report

2020 Report

Icon has a strong technical research culture, including research projects and collaborations with equipment vendors (such as Varian and Siemens), other clinical institutions and universities. These projects operate across nationally across Australian Icon cancer centres. This research often leads to implementation of new techniques or technology, as well as presentation at national and international conferences, or publication in international peer reviewed journals.

Icon currently collaborates with the following research agreements/projects:

  • Megavoltage intrafraction motion monitoring for VMAT treatments
  • 4DCT commissioning on Siemens CT-Simulators
  • Direct Density commissioning on Siemens Confidence CT-Simulators
  • Commissioning of Halcyon™ linear accelerators in developing nations
  • Varian Online Adaptive Consortium
  • TomoTherapy and Halcyon™ comparative study

Icon also has several internally led technical research projects relating to Halcyon™, HyperArc™, motion management and online adaptive radiation therapy and continues to foster our global partnership with Varian Medical Systems to advance radiation oncology.


Contact us